Total Revenue: $337.7 million, an increase of 20.3% from $280.7 million in Q1 2024. Adjusted Earnings Per Share (EPS): $1.42, up 17.4% from $1.21 in Q1 2024. Adjusted EBITDA: $40.6 million, a 25.1% increase from $32.4 million in Q1 2024. Cash on Hand: Approximately $97 million as of March 31, 2025. Bank Debt: Reduced by $20 million to a balance of $203 million at the end of Q1 2025. Personal Care Same-Store Revenue Growth: 7.4% compared to Q1 2024. Hospice Same-Store Revenue Growth: 9.9% compared to Q1 2024. Home Health Same-Store Revenue Growth: 1.3% compared to Q1 2024. Gross Margin Percentage: 31.9%, up from 31.4% in Q1 2024. Adjusted EBITDA Margin: 12%, compared to 11.6% in Q1 2024. Net Cash Flow from Operations: $18.9 million for Q1 2025. Days Sales Outstanding (DSO): 36.9 days at the end of Q1 2025.

Warning! GuruFocus has detected 3 Warning Sign with ADUS.

Release Date: May 06, 2025

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Addus HomeCare Corp (NASDAQ:ADUS) reported a 20.3% increase in total revenue for Q1 2025, reaching $337.7 million compared to the same period in 2024. The company achieved a 25.1% increase in adjusted EBITDA, reaching $40.6 million, indicating strong operational performance. Addus HomeCare Corp (NASDAQ:ADUS) successfully reduced its bank debt by $20 million during the first quarter, showcasing effective debt management. The personal care segment experienced a 7.4% same-store revenue growth, driven by strong hiring trends and favorable rate support. The company maintained a conservative net leverage position, allowing flexibility for strategic acquisition opportunities.

Negative Points

The clinical hiring environment remains challenging and geographically variable, posing difficulties for consistent staffing. Despite improvements, the home health segment only achieved a modest 1.3% same-store revenue growth compared to the previous year. The company faces uncertainties in the home health market due to potential changes in CMS administration and revenue clawbacks. Addus HomeCare Corp (NASDAQ:ADUS) experienced a slight increase in adjusted G&A expenses, rising to 19.9% from 19.8% in the prior year. The company's DSOs for the Illinois Department of Aging increased to 47.6 days, indicating potential cash flow timing issues.

Q & A Highlights

Q: Can you provide commentary on what you're seeing from a capital limitation perspective in hospice?A: W. Bradley Bickham, President and COO, stated that capital limitations have not been very material for Addus. They had a small cap last year, but going forward, it is a very immaterial amount. The company has been managing cap well by ensuring a balanced referral mix in each market.

Story Continues

Q: How should we think about the growth for personal care services for the rest of this year?A: W. Bradley Bickham, President and COO, mentioned that despite some weather events in early January, the company rebounded nicely in February and March. They expect personal care hours to grow in the 2% to 2.5% range going forward.

Q: What is the outlook for hospice revenue growth for the rest of the year?A: W. Bradley Bickham, President and COO, expects hospice revenue growth to be in the 5% to 7% range, likely towards the higher end. The company has seen good average daily census growth and is pleased with the first quarter's performance.

Q: Can you comment on the level and cadence of margin expansion expected through the rest of the year?A: Brian Poff, CFO, explained that Q1 is usually the low point for margins due to seasonality. They expect 40 to 50 basis points of expansion in Q2, with Q2 to Q3 being level. Another step up is expected in Q4 due to payroll tax thresholds and the hospice rate increase effective October 1.

Q: How does the potential rollback of ACA expansion impact Addus HomeCare?A: R. Dirk Allison, CEO, stated that the ACA expansion did not significantly benefit Addus, as their patient base is primarily elderly and disabled, who have long qualified for Medicaid. Therefore, potential rollbacks or changes are not expected to have a direct impact on the company.

Q: How has the Gentiva acquisition performed against expectations?A: W. Bradley Bickham, President and COO, noted that the Gentiva leadership team has done a phenomenal job during the integration process. Financial performance has been slightly stronger than expected on the bottom line, although top-line growth was a bit lighter due to the Texas redetermination process.

Q: What is the current state of workforce retention and hiring across the industry?A: W. Bradley Bickham, President and COO, observed that industry-wide improvement has been seen since the COVID timeframe, particularly in personal care. The clinical side remains challenging but has improved significantly compared to 1.5 to 2 years ago.

Q: How are state budgets and potential rate increases looking for the future?A: Brian Poff, CFO, mentioned that state budgets are in good shape with no large concerns. They have received good rate support in recent years, particularly in Illinois and New Mexico. Texas is being closely watched for potential rate increases, with legislative sessions concluding soon.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

This article first appeared on GuruFocus.

View Comments